Skip to main content
Erschienen in: Heart and Vessels 1/2023

07.09.2022 | Original Article

Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells

verfasst von: LaTonya R. Simon, Ashley J. Scott, Lysmarie Figueroa Rios, Joshua Zembles, Kristyn S. Masters

Erschienen in: Heart and Vessels | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Males acquire calcific aortic valve disease (CAVD) twice as often as females, yet stenotic valves from females display significantly higher levels of fibrosis compared to males with similar extent of disease. Fibrosis occurs as an imbalance between the production and degradation of the extracellular matrix (ECM), specifically type I collagen. This work characterizes ECM production and remodeling by male and female valvular interstitial cells (VICs) to better understand the fibrocalcific divergence between sexes evident in CAVD. Male and female VICs were assessed for gene and protein expression of myofibroblastic markers, ECM components, matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs) via qRT-PCR and western blot. Overall metabolic activity was also measured. Activity assays for collagenase and gelatinase were performed to examine degradation behavior. Male VICs produced greater levels of myofibroblastic markers while female VICs showed greater metabolic activity and collagen production. In general, females displayed a greater level of MMP expression and production than males, but no sex differences were observed in TIMP production. Male VICs also displayed a greater level of collagenase and gelatinase activity than female VICs. This work displays sex differences in ECM remodeling by VICs that could be related to the sexual dimorphism in ECM structure seen in clinical CAVD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P (2016) Calcific aortic stenosis. Nat Rev Dis Prim 2(1):16006CrossRef Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P (2016) Calcific aortic stenosis. Nat Rev Dis Prim 2(1):16006CrossRef
2.
Zurück zum Zitat Liu AC, Joag VR, Gotlieb AI (2007) The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171(5):1407–1418CrossRef Liu AC, Joag VR, Gotlieb AI (2007) The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171(5):1407–1418CrossRef
3.
Zurück zum Zitat Mccoy CM, Nicholas DQ, Masters KS (2012) Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS ONE 7(7):e39980CrossRef Mccoy CM, Nicholas DQ, Masters KS (2012) Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS ONE 7(7):e39980CrossRef
4.
Zurück zum Zitat Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA (2020) Sex-specific features of calcific aortic valve disease. Int J Mol Sci 21(16):5620CrossRef Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA (2020) Sex-specific features of calcific aortic valve disease. Int J Mol Sci 21(16):5620CrossRef
5.
Zurück zum Zitat Cote N, Clavel MA (2020) Sex differences in the pathophysiology, diagnosis, and management of aortic stenosis. Cardiol Clin 38(1):129–138CrossRef Cote N, Clavel MA (2020) Sex differences in the pathophysiology, diagnosis, and management of aortic stenosis. Cardiol Clin 38(1):129–138CrossRef
6.
Zurück zum Zitat Thaden JJ, Nkomo VT, Suri RM, Maleszewski JJ, Soderberg DJ, Clavel MA, Pislaru SV, Malouf JF, Foley TA, Oh JK, Miller JD, Edwards WD, Enriquez-Sarano M (2016) Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight. Eur Heart J 37(8):693–699CrossRef Thaden JJ, Nkomo VT, Suri RM, Maleszewski JJ, Soderberg DJ, Clavel MA, Pislaru SV, Malouf JF, Foley TA, Oh JK, Miller JD, Edwards WD, Enriquez-Sarano M (2016) Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight. Eur Heart J 37(8):693–699CrossRef
7.
Zurück zum Zitat Porras AM, McCoy CM, Masters KS (2017) Calcific aortic valve disease: a battle of the sexes. Circ Res 120(4):604–606CrossRef Porras AM, McCoy CM, Masters KS (2017) Calcific aortic valve disease: a battle of the sexes. Circ Res 120(4):604–606CrossRef
8.
Zurück zum Zitat Simard L, Cote N, Dagenais F, Mathieu P, Couture C, Trahan S, Bosse Y, Mohammadi S, Page S, Joubert P, Clavel MA (2017) Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circ Res 120(4):681–691CrossRef Simard L, Cote N, Dagenais F, Mathieu P, Couture C, Trahan S, Bosse Y, Mohammadi S, Page S, Joubert P, Clavel MA (2017) Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circ Res 120(4):681–691CrossRef
9.
Zurück zum Zitat Voisine M, Hervault M, Shen M, Boilard AJ, Filion B, Rosa M, Bosse Y, Mathieu P, Cote N, Clavel MA (2020) Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc 9(10):e015610CrossRef Voisine M, Hervault M, Shen M, Boilard AJ, Filion B, Rosa M, Bosse Y, Mathieu P, Cote N, Clavel MA (2020) Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc 9(10):e015610CrossRef
10.
Zurück zum Zitat Di Vito A, Donato A, Presta I, Mancuso T, Brunetti FS, Mastroroberto P, Amorosi A, Malara N, Donato G (2021) Extracellular matrix in calcific aortic valve disease: architecture, dynamic and perspectives. Int J Mol Sci 22(2):913CrossRef Di Vito A, Donato A, Presta I, Mancuso T, Brunetti FS, Mastroroberto P, Amorosi A, Malara N, Donato G (2021) Extracellular matrix in calcific aortic valve disease: architecture, dynamic and perspectives. Int J Mol Sci 22(2):913CrossRef
11.
Zurück zum Zitat Stephens EH, Saltarrelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, Olmsted-Davis EA, Reardon MJ, Morrisett JD, Grande-Allen KJ (2011) Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol 20(6):334–342CrossRef Stephens EH, Saltarrelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, Olmsted-Davis EA, Reardon MJ, Morrisett JD, Grande-Allen KJ (2011) Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol 20(6):334–342CrossRef
12.
Zurück zum Zitat Artiach G, Carracedo M, Seime T, Plunde O, Laguna-Fernandez A, Matic L, Franco-Cereceda A, Back M (2020) Proteoglycan 4 is increased in human calcified aortic valves and enhances valvular interstitial cell calcification. Cells 9(3):684CrossRef Artiach G, Carracedo M, Seime T, Plunde O, Laguna-Fernandez A, Matic L, Franco-Cereceda A, Back M (2020) Proteoglycan 4 is increased in human calcified aortic valves and enhances valvular interstitial cell calcification. Cells 9(3):684CrossRef
13.
Zurück zum Zitat Hutson HN, Marohl T, Anderson M, Eliceiri K, Campagnola P, Masters KS (2016) Calcific aortic valve disease is associated with layer-specific alterations in collagen architecture. PLoS ONE 11(9):e0163858CrossRef Hutson HN, Marohl T, Anderson M, Eliceiri K, Campagnola P, Masters KS (2016) Calcific aortic valve disease is associated with layer-specific alterations in collagen architecture. PLoS ONE 11(9):e0163858CrossRef
14.
Zurück zum Zitat Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF, Hagl S, Haase KK, Dempfle CE, Borggrefe M (2004) Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol 93(2):124–130CrossRef Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF, Hagl S, Haase KK, Dempfle CE, Borggrefe M (2004) Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol 93(2):124–130CrossRef
15.
Zurück zum Zitat Edep ME, Shirani J, Wolf P, Brown DL (2000) Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9(5):281–286CrossRef Edep ME, Shirani J, Wolf P, Brown DL (2000) Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9(5):281–286CrossRef
16.
Zurück zum Zitat Masjedi S, Lei Y, Patel J, Ferdous Z (2017) Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells. Heart Vessel 32(2):217–228CrossRef Masjedi S, Lei Y, Patel J, Ferdous Z (2017) Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells. Heart Vessel 32(2):217–228CrossRef
17.
Zurück zum Zitat Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA (2004) Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95(3):253–260CrossRef Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA (2004) Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95(3):253–260CrossRef
18.
Zurück zum Zitat Cote N, El Husseini D, Pepin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H, McKee MD, Simard C, Despres JP, Pibarot P, Bosse Y, Mathieu P (2012) ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol 52(5):1191–1202CrossRef Cote N, El Husseini D, Pepin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H, McKee MD, Simard C, Despres JP, Pibarot P, Bosse Y, Mathieu P (2012) ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol 52(5):1191–1202CrossRef
19.
Zurück zum Zitat Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O’Brien KD (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 113(17):2113–2119CrossRef Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O’Brien KD (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 113(17):2113–2119CrossRef
20.
Zurück zum Zitat Roberts F, Markby G, Dillon S, Farquharson C, MacRae VE (2020) Beyond mineralisation: metabolic functions for matrix mineralisation regulators. J Endocrinol 245(2):R11–R22CrossRef Roberts F, Markby G, Dillon S, Farquharson C, MacRae VE (2020) Beyond mineralisation: metabolic functions for matrix mineralisation regulators. J Endocrinol 245(2):R11–R22CrossRef
21.
Zurück zum Zitat Valiente-Alandi I, Potter SJ, Salvador AM, Schafer AE, Schips T, Carrillo-Salinas F, Gibson AM, Nieman ML, Perkins C, Sargent MA, Huo J, Lorenz JN, DeFalco T, Molkentin JD, Alcaide P, Blaxall BC (2018) Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation 138(12):1236–1252CrossRef Valiente-Alandi I, Potter SJ, Salvador AM, Schafer AE, Schips T, Carrillo-Salinas F, Gibson AM, Nieman ML, Perkins C, Sargent MA, Huo J, Lorenz JN, DeFalco T, Molkentin JD, Alcaide P, Blaxall BC (2018) Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation 138(12):1236–1252CrossRef
22.
Zurück zum Zitat Li LC, Li J, Gao J (2014) Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Expr Ther 351(2):336–343CrossRef Li LC, Li J, Gao J (2014) Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Expr Ther 351(2):336–343CrossRef
23.
Zurück zum Zitat Sadaba JR, Martinez-Martinez E, Arrieta V, Alvarez V, Fernandez-Celis A, Ibarrola J, Melero A, Rossignol P, Cachofeiro V, Lopez-Andres N (2016) Role for galectin-3 in calcific aortic valve stenosis. J Am Heart Assoc 5(11):e004360CrossRef Sadaba JR, Martinez-Martinez E, Arrieta V, Alvarez V, Fernandez-Celis A, Ibarrola J, Melero A, Rossignol P, Cachofeiro V, Lopez-Andres N (2016) Role for galectin-3 in calcific aortic valve stenosis. J Am Heart Assoc 5(11):e004360CrossRef
24.
Zurück zum Zitat Go JL, Prem K, Al-Hijji MA, Qin Q, Noble C, Young MD, Lerman LO, Lerman A (2018) Experimental metabolic syndrome model associated with mechanical and structural degenerative changes of the aortic valve. Sci Rep 8(1):17835CrossRef Go JL, Prem K, Al-Hijji MA, Qin Q, Noble C, Young MD, Lerman LO, Lerman A (2018) Experimental metabolic syndrome model associated with mechanical and structural degenerative changes of the aortic valve. Sci Rep 8(1):17835CrossRef
25.
Zurück zum Zitat Sarajlic P, Plunde O, Franco-Cereceda A, Back M (2021) Artificial intelligence models reveal sex-specific gene expression in aortic valve calcification. JACC Basic Transl Sci 6(5):403–412CrossRef Sarajlic P, Plunde O, Franco-Cereceda A, Back M (2021) Artificial intelligence models reveal sex-specific gene expression in aortic valve calcification. JACC Basic Transl Sci 6(5):403–412CrossRef
26.
Zurück zum Zitat Capoulade R, Clavel MA, Dumesnil JG, Chan KL, Teo KK, Tam JW, Cote N, Mathieu P, Despres JP, Pibarot P, Investigators A (2012) Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol 60(3):216–223CrossRef Capoulade R, Clavel MA, Dumesnil JG, Chan KL, Teo KK, Tam JW, Cote N, Mathieu P, Despres JP, Pibarot P, Investigators A (2012) Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol 60(3):216–223CrossRef
27.
Zurück zum Zitat Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F (2020) Sex related differences in the pathogenesis of organ fibrosis. Transl Res 222:41–55CrossRef Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F (2020) Sex related differences in the pathogenesis of organ fibrosis. Transl Res 222:41–55CrossRef
28.
Zurück zum Zitat Duprez DA, Gross MD, Kizer JR, Ix JH, Hundley WG, Jacobs DR Jr (2018) Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (multi-ethnic study of atherosclerosis). J Am Heart Assoc 7(5):e007885CrossRef Duprez DA, Gross MD, Kizer JR, Ix JH, Hundley WG, Jacobs DR Jr (2018) Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (multi-ethnic study of atherosclerosis). J Am Heart Assoc 7(5):e007885CrossRef
29.
Zurück zum Zitat Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP (2011) The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the cardiovascular health study. Circulation 4(6):733–739 Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP (2011) The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the cardiovascular health study. Circulation 4(6):733–739
30.
Zurück zum Zitat Li Z, Wang Z, Yin Z, Zhang Y, Xue X, Han J, Zhu Y, Zhang J, Emmert MY, Wang H (2017) Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget 8(32):53714–53729CrossRef Li Z, Wang Z, Yin Z, Zhang Y, Xue X, Han J, Zhu Y, Zhang J, Emmert MY, Wang H (2017) Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget 8(32):53714–53729CrossRef
31.
Zurück zum Zitat Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH (2005) Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 166(6):1593–1606CrossRef Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH (2005) Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 166(6):1593–1606CrossRef
32.
Zurück zum Zitat Rodriguez KJ, Piechura LM, Porras AM, Masters KS (2014) Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification. BMC Cardiovasc Disord 14:29CrossRef Rodriguez KJ, Piechura LM, Porras AM, Masters KS (2014) Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification. BMC Cardiovasc Disord 14:29CrossRef
33.
Zurück zum Zitat Monzack EL, Gu X, Masters KS (2009) Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. Arterioscler Thromb Vasc Biol 29(2):246–253CrossRef Monzack EL, Gu X, Masters KS (2009) Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. Arterioscler Thromb Vasc Biol 29(2):246–253CrossRef
34.
Zurück zum Zitat Matilla L, Roncal C, Ibarrola J, Arrieta V, Garcia-Pena A, Fernandez-Celis A, Navarro A, Alvarez V, Gainza A, Orbe J, Cachofeiro V, Zalba G, Sadaba R, Rodriguez JA, Lopez-Andres N (2020) A role for MMP-10 (matrix metalloproteinase-10) in calcific aortic valve stenosis. Arterioscler Thromb Vasc Biol 40(5):1370–1382CrossRef Matilla L, Roncal C, Ibarrola J, Arrieta V, Garcia-Pena A, Fernandez-Celis A, Navarro A, Alvarez V, Gainza A, Orbe J, Cachofeiro V, Zalba G, Sadaba R, Rodriguez JA, Lopez-Andres N (2020) A role for MMP-10 (matrix metalloproteinase-10) in calcific aortic valve stenosis. Arterioscler Thromb Vasc Biol 40(5):1370–1382CrossRef
35.
Zurück zum Zitat Freeman RV, Otto CM (2005) Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111(24):3316–3326CrossRef Freeman RV, Otto CM (2005) Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111(24):3316–3326CrossRef
36.
Zurück zum Zitat Leopold JA (2012) Cellular mechanisms of aortic valve calcification. Circulation 5(4):605–614 Leopold JA (2012) Cellular mechanisms of aortic valve calcification. Circulation 5(4):605–614
Metadaten
Titel
Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells
verfasst von
LaTonya R. Simon
Ashley J. Scott
Lysmarie Figueroa Rios
Joshua Zembles
Kristyn S. Masters
Publikationsdatum
07.09.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 1/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02164-2

Weitere Artikel der Ausgabe 1/2023

Heart and Vessels 1/2023 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.